Literature DB >> 6235075

Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.

R Maccario, A G Ugazio, L Nespoli, C Alberini, D Montagna, F Porta, F Bonetti, G R Burgio.   

Abstract

Peripheral blood lymphomononuclear cells (PBL) from 35 patients with Down's syndrome (DS, trisomy-21; 25 institutionalized and 10 non-institutionalized) were phenotypically characterized by means of various monoclonal antibodies. They included a high percentage of T lymphocytes with low avidity for sheep erythrocytes as well as an extremely high percentage of HNK-1+ cells and of lymphocytes reacting with the OKT8 and Leu 2a antibodies. The HNK-1+ cells of DS include four different subsets: (a) E+, OKT3+, OKT8-, Leu 2a-; (b) E+, OKT3+, OKT8+, Leu 2a+; (c) E-, OKT3-, OKT8-, Leu 2a- and (d) E-, OKT3-, OKT8+, Leu 2a+. Subsets (a) and (c) are also present in PBL from karyotypically normal controls while subsets (b) and (d) have a phenotype which has not been previously reported. These findings may be related to the triple expression by trisomic cells of the receptor for interferon, which is coded by a gene located on chromosome number 21. Alternatively, the high number of 'immature' NK cells of DS, possibly identical with pre-T lymphocytes, may originate from the congenital thymic derangement associated with trisomy 21.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235075      PMCID: PMC1536096     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  46 in total

1.  T system immune-deficiency in Down's syndrome.

Authors:  S Levin; E Nir; B M Mogilner
Journal:  Pediatrics       Date:  1975-07       Impact factor: 7.124

2.  Defective antibody response to bacteriophage phichi 174 in Down syndrome.

Authors:  V Lopez; H D Ochs; H C Thuline; S D Davis; R J Wedgwood
Journal:  J Pediatr       Date:  1975-02       Impact factor: 4.406

3.  Mortality and life-table in Down's syndrome.

Authors:  J Oster; M Mikkelsen; A Nielsen
Journal:  Acta Paediatr Scand       Date:  1975-03

4.  Chromosome-21-dosage effect on inducibility of anti-viral gene(s).

Authors:  U H Tan
Journal:  Nature       Date:  1975-01-24       Impact factor: 49.962

5.  Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.

Authors:  G Henle; W Henle
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

6.  Mongols and non-mongols compared in their response to active tetanus immunisation.

Authors:  A W Griffiths; P E Sylvester
Journal:  J Ment Defic Res       Date:  1967-12

7.  Antibody responses to influenza vaccine in patients with Down's syndrome.

Authors:  M C Gordon; S K Sinha; S D Carlson
Journal:  Am J Ment Defic       Date:  1971-01

8.  Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages.

Authors:  G R Burgio; A G Ugazio; L Nespoli; A F Marcioni; A M Bottelli; F Pasquali
Journal:  Eur J Immunol       Date:  1975-09       Impact factor: 5.532

9.  Stress deficiency of the T-lymphocyte system exemplified by Down syndrome.

Authors:  S Whittingham; D B Pitt; D L Sharma; I R Mackay
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321

10.  THE THYMUS IN MONGOLISM.

Authors:  C E BENDA; G S STRASSMANN
Journal:  J Ment Defic Res       Date:  1965-06
View more
  12 in total

1.  Differential expression of lymphocyte function-associated antigen (LFA-1) on peripheral blood leucocytes from individuals with Down's syndrome.

Authors:  M J Barrena; P Echaniz; C Garcia-Serrano; P Zubillaga; E Cuadrado
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

2.  Abnormality of Leu 2+7+ cells in acquired immune deficiency syndrome (AIDS), AIDS-related complex, and asymptomatic homosexuals.

Authors:  S Gupta
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

3.  Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.

Authors:  S Raziuddin; M E Elawad
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

4.  Increased activity of oligo-2',5'-adenylate synthetase in Down's syndrome and epilepsy.

Authors:  N Fujii; K Oguma; M Fujii; R Fukatsu; N Takahata; M Kitabatake
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

5.  T cell response to anti-CD3 antibody in Down's syndrome.

Authors:  A Bertotto; C Arcangeli; S Crupi; I Marinelli; R Gerli; R Vaccaro
Journal:  Arch Dis Child       Date:  1987-11       Impact factor: 3.791

6.  Natural killer cells in Behçet's disease.

Authors:  K Hamzaoui; K Ayed; M Hamza; J L Touraine
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

7.  Cell-mediated cytotoxicity in Down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activities.

Authors:  D Montagna; R Maccario; A G Ugazio; L Nespoli; E Pedroni; P Faggiano; G R Burgio
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

8.  Altered DNA methylation in leukocytes with trisomy 21.

Authors:  Kristi Kerkel; Nicole Schupf; Kota Hatta; Deborah Pang; Martha Salas; Alexander Kratz; Mark Minden; Vundavalli Murty; Warren B Zigman; Richard P Mayeux; Edmund C Jenkins; Ali Torkamani; Nicholas J Schork; Wayne Silverman; B Anne Croy; Benjamin Tycko
Journal:  PLoS Genet       Date:  2010-11-18       Impact factor: 5.917

9.  The first case of isolated facial cutanenous leishmaniasis in a Down syndrome infant: a case report and review of the literature.

Authors:  Kotb Abass; Hekma Saad; Alaa A Abd-Elsayed
Journal:  Cases J       Date:  2009-01-06

10.  Changes in beta-adrenoceptors and leucocyte subpopulations after physical exercise in normal subjects.

Authors:  R Landmann; M Portenier; M Staehelin; M Wesp; R Box
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.